Can amiodarone cause hypothyroidism?

Yes, Amiodarone Causes Hypothyroidism

Amiodarone definitively causes hypothyroidism in 2-4% of patients in most series, with some reports showing rates as high as 8-10%, and recent evidence suggests cumulative incidence may reach 21.8% at 5 years 1, 2.

Mechanism and Epidemiology

Amiodarone is an iodine-containing compound (37% iodine by molecular weight) that causes thyroid dysfunction through multiple mechanisms 1, 3:

• Inhibits peripheral conversion of T4 to T3, leading to increased T4 levels and decreased T3 levels even in euthyroid patients
• Releases large amounts of inorganic iodine that can directly impair thyroid function
• Direct cytotoxic effects on thyroid cells from amiodarone or its metabolite desethylamiodarone

The overall incidence of amiodarone-induced thyroid dysfunction is substantial. A 2025 Icelandic nationwide cohort study found the 5-year cumulative incidence of amiodarone-induced hypothyroidism (AIH) was 21.8%, with the highest yearly incidence rate of 9.8% occurring during the first treatment year 2. A 2023 meta-analysis of 14,143 patients confirmed an AIH prevalence of 14% (95% CI: 12-17%), with no significant gender difference 4.

Clinical Recognition

Hypothyroidism should be identified by:

• Elevated serum TSH levels (primary diagnostic marker)
• Relevant clinical symptoms (though free thyroxine index values may be normal in some clinically hypothyroid patients) 1
• Clinical manifestations in elderly patients may be subtle or atypical, mimicking normal aging 5

Monitoring Requirements

Thyroid function testing is mandatory:

• Before initiating amiodarone therapy (baseline)
• At 1 and 3 months after starting treatment
• Every 3-6 months thereafter during continued therapy 6

This monitoring schedule is critical because the highest risk period for AIH is during the first year of treatment 2, and thyroid dysfunction can persist for weeks to months after amiodarone discontinuation due to its long half-life (averaging 58 days) and slow release from lipid-rich tissues 7, 1.

Management Approach

For amiodarone-induced hypothyroidism:

1. First-line management: Continue amiodarone with thyroid hormone replacement 1

   • Start levothyroxine supplementation
   • Adjust dose based on TSH monitoring
   • Amiodarone can be safely continued when hypothyroidism is successfully treated with replacement therapy 8

2. Consider dose reduction of amiodarone as an adjunct to levothyroxine 1

3. Discontinue amiodarone only if necessary - therapy must be individualized, and discontinuation may be required in some patients 1

Critical distinction: Unlike amiodarone-induced hyperthyroidism (which poses greater hazard due to risk of thyrotoxicosis, arrhythmia breakthrough, and death), hypothyroidism is generally more straightforward to manage and does not typically require amiodarone discontinuation 1.

Clinical Pitfalls

• Don't assume normal thyroid function persists - nearly 40% of patients develop thyroid dysfunction within 5 years 2
• Don't rely solely on clinical symptoms - elderly patients may have non-specific presentations 5
• Don't stop monitoring - dysfunction can develop at any point during therapy, with peak risk in year 1 for hypothyroidism 2
• Don't forget post-discontinuation monitoring - thyroid abnormalities may persist for weeks to months after stopping amiodarone due to its extremely long half-life 7, 1

The evidence consistently demonstrates that amiodarone is a frequent and well-established cause of hypothyroidism, requiring systematic monitoring and proactive management to prevent morbidity while maintaining arrhythmia control 5, 9, 3.